Skip to main content

Zoetis Inc. (ZTS) Stock

Zoetis Inc. Stock Details, Movements and Public Alerts

Stock Details

Zoetis Inc. (ZTS), a prominent company in the life sciences sector within the pharmaceutical preparations industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $156.06. Over the past 52 weeks, it has ranged between $139.22 and $198.58. This places the current price at 78.6% of its 52-week high and 12.1% above its 52-week low. Recent trading volume was recorded at 36,290. The International Securities Identification Number (ISIN) for this stock is US98978V1035.

Market Cap

$69.53B

52-Week High

$198.58

-21.41% from high

52-Week Low

$139.22

+12.10% from low

Avg Daily Volume

36,290

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

27.99

Above market average

Forward P/E

25.25

Earnings expected to grow

PEG Ratio

2.66

Potentially overvalued

Price to Book

14.94

EV/EBITDA

19.08

EPS (TTM)

$5.58

Price to Sales

7.49

Beta

0.94

Less volatile than market

How is ZTS valued relative to its earnings and growth?
Zoetis Inc. trades at a P/E ratio of 27.99, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 25.25 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 2.66 indicates a premium valuation even accounting for growth.
What is ZTS's risk profile compared to the market?
With a beta of 0.94, Zoetis Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 14.94 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

27.10%

Operating Margin

38.10%

Return on Equity

52.10%

Return on Assets

15.10%

Revenue Growth (YoY)

1.40%

Earnings Growth (YoY)

7.80%

How profitable and efficient is ZTS's business model?
Zoetis Inc. achieves a profit margin of 27.10%, meaning it retains $27.10 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of 38.10% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 52.10% and ROA at 15.10%, the company generates strong returns on invested capital.
What are ZTS's recent growth trends?
Zoetis Inc.'s revenue grew by 1.40% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 7.80% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against PHARMACEUTICAL PREPARATIONS industry averages for proper context.

Dividend Information

Dividend Per Share

$1.80

Dividend Yield

1.28%

Ex-Dividend Date

7/18/2025

Dividend Date

9/3/2025

What dividend income can investors expect from ZTS?
Zoetis Inc. offers a dividend yield of 1.28%, paying $1.80 per share annually. This modest yield below 2% suggests the company prioritizes growth investments over current income. While the dividend provides some return, investors are likely attracted more by capital appreciation potential than income generation. To receive the next dividend, shares must be purchased before the ex-dividend date of 7/18/2025.
How reliable is ZTS's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - Zoetis Inc. pays $1.80 per share in dividends against earnings of $5.58 per share, resulting in a payout ratio of 32.19%. This balanced payout between 30-60% suggests a sustainable dividend policy that allows both shareholder returns and business reinvestment. The dividend appears well-covered by earnings. The next dividend payment is scheduled for 9/3/2025.

Company Size & Market

Shares Outstanding

445.21M

Book Value/Share

$10.44

Asset Type

Common Stock

What is ZTS's market capitalization and position?
Zoetis Inc. has a market capitalization of $69.53B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 445.21M shares outstanding, the company's ownership is relatively concentrated. As a participant in the PHARMACEUTICAL PREPARATIONS industry, it competes with other firms in this sector.
How does ZTS's price compare to its book value?
Zoetis Inc.'s book value per share is $10.44, while the current stock price is $156.06, resulting in a price-to-book (P/B) ratio of 14.95. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$195.04

24.98% upside potential

Analyst Recommendations

Strong Buy

4

Buy

10

Hold

5

Sell

0

Strong Sell

0

How reliable are analyst predictions for ZTS?
19 analysts cover ZTS with 74% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $195.04 implies 25.0% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on ZTS?
Current analyst recommendations:4 Strong Buy, 10 Buy, 5 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 1, 2025, 03:16 AM

Technical Indicators

What does ZTS's RSI value tell investors?
RSI data is not available for this stock.
How should traders interpret ZTS's MACD and moving average crossovers?
MACD and moving average data are not available for this stock.

No technical indicators available yet.

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for ZTS and get notified when the price changes.

Stay Ahead of the Market with Zoetis Inc. Alerts

Set up price alerts for Zoetis Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.